For the study, researchers with the Boston University School of Public Health examined the association between HDHP enrollment and access to care by race and ethnicity among cancer survivors.
The study authors used data from the National Health Interview Survey to examine this association, with 3,713 cancer survivors represented in the data. In one example, they found Black cancer survivors with an HDHP were more likely to skip medication to save money than white cancer survivors with HDHPs (22.8 percent versus 8 percent, respectively).
“This study found that the magnitude of association between HDHPs and cost-related barriers to care is larger among black cancer survivors relative to their white counterparts, elucidating the potential for HDHPs to widen documented racial/ethnic disparities in cancer outcomes.”
Read the full study here.
More articles on payers:
10 top Medicare Advantage plans, ranked by members
CVS to open Aetna office, hire 500
Blue Shield of California launches 20 pilot projects, including settling claims in real time
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
